Valuation Shenyang Xingqi Pharmaceutical Co.,Ltd.

Stocks

End-of-day quote Shenzhen S.E. Other stock markets 2026-07-10			5-day change	1st Jan Change
40.59 ^CNY	+2.24%		-3.59%	-16.27%

06-30	Shenyang Xingqi Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	CI
06-28	Shenyang Xingqi Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	7,612	11,263	11,076	22,715	12,229	17,322
Change	-	47.96%	-1.66%	105.08%	-46.16%	41.64%
Enterprise Value (EV) ¹	7,655	10,688	10,575	22,314	12,074	17,010
Change	-	39.62%	-1.06%	111.01%	-45.89%	40.88%
P/E	88.2x	57.5x	51.9x	94.5x	36.2x	24.8x
PBR	11.5x	8.96x	7.14x	13.4x	7.68x	8.76x
PEG	-	0x	38.03x	7.8x	0.9x	0x
Capitalization / Revenue	11.1x	11x	8.86x	15.5x	6.29x	7x
EV / Revenue	11.1x	10.4x	8.46x	15.2x	6.21x	6.88x
EV / EBITDA	50.9x	36x	35.8x	66.1x	24.2x	18.7x
EV / EBIT	72.6x	44.5x	45.7x	85.8x	29.6x	21x
EV / FCF	-459x	84x	-79.4x	-1,071x	58.1x	38.1x
FCF Yield	-0.22%	1.19%	-1.26%	-0.09%	1.72%	2.62%
Dividend per Share ²	0.0628	0.1634	0.377	1.302	0.7389	1.172
Rate of return	0.26%	0.48%	1.2%	2.03%	2.15%	2.42%
EPS ²	0.2714	0.5975	0.6057	0.6791	0.9507	1.952
Distribution rate	23.1%	27.3%	62.2%	192%	77.7%	60.1%
Net sales ¹	688.7	1,028	1,250	1,468	1,943	2,473
EBITDA ¹	150.2	296.8	295.5	337.8	499.8	911.5
EBIT ¹	105.4	240.3	231.2	259.9	408.4	810.5
Net income ¹	87.98	194.7	211.7	240	338.1	695.9
Net Debt ¹	42.78	-575.1	-501.6	-401.3	-154.8	-311.7
Reference price ²	23.93	34.38	31.44	64.15	34.37	48.48
Nbr of stocks (in thousands)	318,047	327,585	352,343	354,082	355,756	357,323
Announcement Date	4/19/21	4/19/22	4/19/23	4/18/24	4/21/25	4/21/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-	-	-	-	2.09B
MERCK & CO., INC.	61.31x	5.2x	21.64x	2.68%	309B
MERCK KGAA	23.65x	3.25x	11.58x	1.67%	69.38B
HALOZYME THERAPEUTICS, INC.	11.68x	5.93x	9.14x	-	9.33B
KYOWA KIRIN CO., LTD.	17.38x	2.21x	7.61x	2.57%	8.62B
SK BIOPHARMACEUTICALS CO., LTD.	21.39x	6.06x	17.14x	-.--%	4.16B
BETTA PHARMACEUTICALS CO., LTD.	34.66x	6.56x	18.75x	-	4.01B
YUHAN CORPORATION	37.42x	2.12x	26.07x	0.82%	3.33B
SUPERNUS PHARMACEUTICALS, INC.	112.5x	-	-	-.--%	2.83B
Average	40.00x	4.47x	15.99x	1.29%	45.85B
Weighted average by Cap.	52.39x	4.82x	19.31x	2.44%